v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-Based Compensation Expense

The following table summarizes the components of total stock-based compensation expense included in the condensed consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

Research and development

 

$

512

 

 

$

613

 

 

$

1,747

 

 

$

2,044

 

 

General and administrative

 

 

623

 

 

 

943

 

 

 

2,413

 

 

 

2,536

 

 

Total stock-based compensation expense

 

$

1,135

 

 

$

1,556

 

 

$

4,160

 

 

$

4,580

 

 

Summary of Assumptions Used to Estimate Fair Values of Stock Options Grants

The fair value of stock options granted during the periods indicated was estimated using the Black-Scholes option pricing model, based on the following assumptions:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2023

 

2022

 

2023

 

2022

Exercise price

 

$0.98

 

$1.66 - $2.19

 

$0.89 - $1.53

 

$1.53 - $2.45

Expected volatility

 

77.5% - 83.1%

 

78.6% - 81.7%

 

77.5% - 83.1%

 

78.6% - 81.7%

Risk-free rate

 

4.23% - 4.24%

 

2.62% - 4.15%

 

3.59% - 4.24%

 

1.41% - 4.15%

Expected term (years)

 

5.5 - 7.0

 

5.5 - 7.0

 

5.5 - 7.5

 

5.5 - 7.5

Expected dividend yield

 

0%

 

0%

 

0%

 

0%